drugset / Trial / NCT02321865

Dose Adjustment Study of NPC-02 in Patients With Zinc Deficiency

NCT02321865

Phase 3 Completed 43 enrolled Nobelpharma
NaSingle-groupOpen-labelTreatment

Summary

The objective of this study is to check the dose control method of NPC-02 and the holding effect for the target serum zinc concentration in patients with zinc deficiency.

Timeline

Start
2015-01-21
Primary completion
2015-11
Completion
2015-11-24

Drugs

EvaluationDrugModalityDoseRoute
Subject Zinc Sulfate Unknown